A team from the Research Center Hospital of the University of Quebec-Laval say they have found how to neutralize the cells that attack the brain, spine and brain.
The study results, published in the Journal of Experimental Medicine, found the involvement of a molecule in the development of multiple sclerosis - the interleukin IL-1 beta molecule - was important in the development of brain inflammation and autoimmunity in conditions such as multiple sclerosis.
In a mouse study, it was discovered that when this molecule is blocked, rodents did not develop multiple sclerosis. Lacroix said deleting the gene of interest, the famous immune cells that attack the brain, spinal cord, neurons and myelin are unable to enter the central nervous system and cause death and permanent damage to nerve cells. The influx of immune cells in the central nervous system is associated with the appearance of plaques around nerves and neurons, causing cognitive and motor disorders in multiple sclerosis.
The discovery of the involvement of interleukin IL-1 beta could now offer a new focus for multiple sclerosis treatments.
Source: Science News Hub © Copyright NewsLodi 2016 (13/05/16)